Walgreens Boots Alliance, Inc.
—- Market cap
- —
- Debt
- +$11.09B
- Cash
- −$3.11B
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: WBA stock price vs NOW: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at NOW's multiple
Needs NOW P/S.
Implied fair value · at WBA's multiple
Needs WBA P/S.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: WBA FY 2024 (ended Aug 31, 2024) · NOW FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
WALGREENS BOOTS ALLIANCE, INC. · implied price per share
Bear
-$116.28
Base
-$136.80
Bull
-$157.32
ServiceNow, Inc. · implied price per share
Bear
$22.00
Base
$25.89
Bull
$29.77
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
1.06x
0.01x
Net debt / EBITDA
Leverage against operating earnings
-2.06x
-1.59x
Cash and equivalents
Liquid reserves on the balance sheet
$3.11B
$4.78B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
CVS HEALTH Corp
WBA vs CVS
Walmart Inc.
WBA vs WMT
KROGER CO
WBA vs KR
Cigna Group
WBA vs CI
UNITEDHEALTH GROUP INC
WBA vs UNH
MICROSOFT CORP
WBA vs MSFT
ADOBE INC.
WBA vs ADBE
ORACLE CORP
WBA vs ORCL
Salesforce, Inc.
WBA vs CRM
INTERNATIONAL BUSINESS MACHINES CORP
WBA vs IBM
Paycom Software, Inc.
WBA vs PAYC
$11.09B
$92.00M
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
Based on an earlier data snapshot. Review the filing dates below or refresh after signing in.
If you believe WBA can sustainably reverse its negative margins and ROIC toward positive levels, then consider the stock only as a turnaround case; otherwise avoid relative exposure because NOW’s data show far stronger growth, profitability, and balance-sheet quality.
The only valuation input provided is an implied price of $1,479.06 based on a P/S framework, but no actual current price or valuation range is available to judge discount or premium precisely. Even so, the operating profile behind that anchor is dramatically stronger for NOW, which justifies a much richer multiple than WBA.
Supporting Metrics